Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Nxera Pharma surges again, briefly hitting daily limit as partner Centessa to be acquired by Eli Lilly
Nxera Pharma Co., Ltd. <4565> surged again, briefly hitting the daily limit up at \1,022, up \150 from the previous trading day. Partner company UK-based Centessa Pharmaceuticals
The OX2 agonist series aims to treat a wide range of diseases related to sleep-wake regulation and other conditions. The series was jointly created by Nxera and Centessa under a partnership that grants Centessa access to Nxera's NxStaR (stabilized receptor) technology.
Source: MINKABU PRESS
Related Articles
MIRAINI Holdings Surges on Planned \8.8 Billion Negative Goodwill Gain in Q1 FY03/27
KYORIN Pharma Surges on License Agreement with France's Biodol for Neuropathic Pain Drug Candidate
GNI Group surges after three-day decline on forecast of consecutive record-high sales for December 2026
Minkabu Individual Investor Sentiment: Tokio Marine Ranks 4th in Rising Sell Predictions
Investment Money Flows into Defense-Related Stocks Including Mitsubishi Heavy as Global Geopolitical Risks Intensify, Triggering Fresh Buying
JELLY BEANS Continues to Rise on Plans to Establish SPC for Recycled Heavy Oil Refinery Business Through Subsidiary
"Rare Earths" Ranks 3rd as Mitsubishi Materials Pursues Critical Minerals Recycling in U.S. - Featured Theme
Apa Holdings Acquires Over 5% Stake in WASHINGTON HOTEL, Cites 'Pure Investment' Purpose
SAMCO shares surge to 9,000 yen level on renewed buying in AI data center-related stocks
SAKURAI shares plunge on securities surveillance designation